Bath & Body Works (NYSE:BBWI – Get Free Report) is projected to post its Q4 2026 results before the market opens on Wednesday, March 4th. Analysts expect Bath & Body Works to post earnings of $1.76 per share and revenue of $2.5942 billion for the quarter. Investors may review the information on the company’s upcoming Q4 2026 earning report for the latest details on the call scheduled for Wednesday, March 4, 2026 at 8:30 AM ET.
Bath & Body Works Trading Down 2.5%
Shares of Bath & Body Works stock opened at $22.73 on Monday. The firm has a market capitalization of $4.65 billion, a PE ratio of 7.00, a price-to-earnings-growth ratio of 1.00 and a beta of 1.48. The firm’s 50 day moving average is $22.13 and its 200 day moving average is $23.68. Bath & Body Works has a 1 year low of $14.27 and a 1 year high of $37.29.
Bath & Body Works Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, March 6th. Stockholders of record on Friday, February 20th will be issued a dividend of $0.20 per share. The ex-dividend date is Friday, February 20th. This represents a $0.80 annualized dividend and a dividend yield of 3.5%. Bath & Body Works’s dividend payout ratio is 24.62%.
Hedge Funds Weigh In On Bath & Body Works
Wall Street Analyst Weigh In
BBWI has been the subject of several research reports. Raymond James Financial reiterated a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday, November 12th. Telsey Advisory Group raised their price objective on shares of Bath & Body Works from $17.00 to $23.00 and gave the company a “market perform” rating in a report on Friday. Jefferies Financial Group began coverage on shares of Bath & Body Works in a research report on Wednesday, January 14th. They set a “hold” rating and a $24.00 target price on the stock. Morgan Stanley reissued an “equal weight” rating and set a $18.00 target price (down from $43.00) on shares of Bath & Body Works in a report on Friday, November 21st. Finally, UBS Group raised their price target on shares of Bath & Body Works from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Monday, February 23rd. Three analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $23.71.
View Our Latest Research Report on Bath & Body Works
Bath & Body Works News Summary
Here are the key news stories impacting Bath & Body Works this week:
- Positive Sentiment: Telsey Advisory Group raised its price target on BBWI from $17 to $23 and kept a “market perform” rating, signaling modest analyst confidence in the company’s near-term outlook (small upside vs. current price). This can provide some support to the stock if other news is neutral. Telsey price target note
- Positive Sentiment: Bath & Body Works launched a limited-time PEEPS® fragrance and gifting collection — a seasonal product tie-in that can help drive traffic and gift-season sales if consumer demand is solid. Product collaborations are usually modest near-term positives rather than transformational. PEEPS collaboration
- Neutral Sentiment: Zacks published a preview of Wall Street projections for Bath & Body Works’ fiscal Q4 results and key metrics. Analysts’ consensus expectations for revenue, comp sales and margins will be important when BBWI reports; the preview itself doesn’t move the stock but sets the bar for the upcoming earnings reaction. Zacks Q4 preview
- Negative Sentiment: Multiple law firms (Rosen, Faruqi & Faruqi, Pomerantz, Bernstein Liebhard, The Gross Law Firm and others) have issued shareholder alerts about a securities class action covering purchases between June 4, 2024 and November 19, 2025 and are urging investors to file by mid-March deadlines (March 13–16, 2026). Heightened litigation activity increases legal and settlement risk and can weigh on the stock, especially while deadlines and potential lead-plaintiff developments are pending. See representative notices: Rosen notice Faruqi notice Gross Law Firm notice
Bath & Body Works Company Profile
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
Featured Stories
- Five stocks we like better than Bath & Body Works
- America’s 1776 happening again
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- This makes me furious
- Elon Musk: This Could Turn $100 into $100,000
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
